Argent Biopharma Limited has released a press release.
COVID-19 Clinical Trial Site Expansion into India
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- MXC Awarded 3-year EU GMP Manufacturing Licence
- Sale of MGC Nutra to US CBD and Hemp Wellness Company
- Binding Term Sheet for distribution of CannEpil in Israel
- 3,250 Prescriptions Milestone Surpassed
- Ethics Committee Approval for CannEpil Phase IIb Trial
Later from Argent Biopharma
- MGC Pharma awarded Import Licence by Office of Drug Control
- MXC Cannabis Research Permit Granted for RMIT Programs
- MGC Pharma to acquire 100% of Medicinal Cannabis Clinic
- Suspension from Official Quotation
- Reinstatement to Official Quotation
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma